Endothelial cell-mediated antigen presentation

Transfusion Medicine and Hemotherapy

Volumn 33, Issue 1, 2006, Pages 58-70

  Johnson, David R ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Endothelial cells; Immune tolerance; Transgenes; Transplantation tolerance

Indexed keywords

B7 ANTIGEN; BACTERIAL ANTIGEN; BETA GALACTOSIDASE; CD2 ANTIGEN; CD28 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DNA; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ATHEROSCLEROSIS; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CARDIOVASCULAR DISEASE; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; CORONARY BLOOD VESSEL; DENDRITIC CELL; DISEASE ASSOCIATION; ENDOTHELIUM CELL; GENE EXPRESSION; HEART TRANSPLANTATION; HISTOCOMPATIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INFECTION; INFLAMMATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN TRANSPLANTATION; REGULATORY T LYMPHOCYTE; REVIEW; SKIN GRAFT; SKIN TRANSPLANTATION; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; TRANSPLANTATION TOLERANCE; VASCULAR ENDOTHELIUM;

EID: 33644552136     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090195     Document Type: Review

References (130)

1. Rothermel A, Wang Y, Scheduler J, Mook-Kanamori B, Aird W, Pober J, Tellides G, Johnson D: Endothehal cells present antigens in vivo. BMC Immunol 2004;5(1):5.
2. Choi J, Enis D, Koh K, Shiao S, Pober J: T lymphocyte-endothelial cell interactions. Annu Rev Immunol 2004;22:683-709.
3. Salmi M, Jalkanen S: Cell-surface enzymes in control of leukocyte trafficking. Nat Rev Immunol 2005;5(10):760-771.
4. Cooper M, Lawton A 3rd: Primary Immune Deficiency Diseases (chapter 307); in Fauci A, et al (eds): Principles of Internal Medicine. New York, McGraw-Hill, 1998, pp 1783-1791.
5. Germain R: MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994;76(2):287-299.
6. Janeway C Jr, Bottomly K: Signals and signs for lymphocyte activation. Cell 1994;76(2):275-285.
7. Johnson DR, Mook-Kanamori B: Dependence of elevated HLA class I molecule expression on increased heavy chain, light chain (β2m), TAP, tapasin, and peptide. J Biol Chem 2000;275(22):16643-16649.
8. Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ: The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation 1984;38(3):287-292.
9. Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ: The detailed distribution of MHC Class II antigens in normal human organs. Transplantation 1984;38(3):293-298.
10. Choo J, Seebach J, Nickeleit V, Shimizu A, Lei H, Sachs D, Madsen J: Species differences in the expression of major histocompatibility complex class II antigens on coronary artery endothelium: implications for cell-mediated xenoreactivity. Transplantation 1997;64(9):1315-1322.
11. Kreisel D, Krasinskas A, Krupnick A, Gelman A, Balsara K, Popma S, Riha M, Rosengard A, Turka L, Rosengard B: Vascular endothelium does not activate CD4+ direct allorecognition in graft rejection. J Immunol 2004;173(5):3027-3034.
12. Karasin A, Macvilay S, Hart M, Fabry Z: Murine endothelia do not express MHC class II I-Ealpha subunit and differentially regulate I-Aalpha expression along the vascular tree. Endothelium 1998;6(2):83-93.
13. Goes N, Urmson J, Hobart M, Halloran P: The unique role of interferon-γ in the regulation of MHC expression on arterial endothelium. Transplantation 1996;62:1889-1894.
14. Schumacher TN, de Bruijn ML, Vernie LN, Kast WM, Melief CJ, Neefjes JJ, Ploegh HL: Peptide selection by MHC class I molecules. Nature 1991;350(6320):703-706.
15. Townsend A, Rothbard J, Gotch F, Bahadur B, Wraith D, McMichael A: The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 1986;44(959):959-968.
16. Benichou G, Valujskikh A, Heeger PS: Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J Immunol 1999;162(1):352-358.
17. Fuchs EJ, Matzinger P: B cells turn off virgin but not memory T cells. Science 1992;258(5085):1156-1159.
18. Unanue E: Macrophages, antigen-presenting cells, and the phenomena of antigen handling and presentation; in Paul W (ed): Fundamental Immunology. New York, Raven Press, 1993, pp 111-144.
19. Ashida E, Johnson A, Lipsky P: human endothelial cell-lymphocyte interaction: endothelial cells fuction as accessory cells necessary for mitogen-induced human T lymphocyte activation in vitro. J Clin Invest 1981;67:1490-1499.
20. Liu Y, Wenger R, Zhao M, Nielsen P: Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes. J Exp Med 1997;185:251-262.
21. Schwartz R: Co-stimulation of T-lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992;71:1065-1068.
22. Gribben J, Freeman G, Boussiotis V, Rennert P, Jellis C, Greenfield E, Barber M, Restivo V Jr, Ke X, Gray G, Nadler L: CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci U S A 1995;92:811-815.
23. Boise L, Noel P, Thompson C: CD28 and apoptosis. Curr Opin Immunol 1995;7(5):620-625.
24. Gimmi C, Freeman G, Gribben J, Gray G, Nadler L: Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci U S A 1993;90:6586-6590.
25. Boussiotis V, Freeman G, Gray G, Gribben J, Nadler L: B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. J Exp Med 1993;178(5):1753-1763.
26. Lombardi G, Sidhu S, Dodi T, Batchelor R, Lechler R: Failure of correlation between B7 expression and activation of interleukin-2-secreting T cells. Eur J Immunol 1994;24(3):523-530.
27. Shahinian A, Pfeffer K, Lee K, Kundig T, Kishihara K, Wakeham A, Kawai K, Ohashi P, Thompson C, Mak T: Differential T cell costimulatory requirements in CD28-deficient mice. Science 1993;261(5121):609-612.
28. Watts T: TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 2005;23:23-68.
29. Karmann K, Min W, Fanslow WC, Pober JS: Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1. J Exp Med 1996;184(1):173-182.
30. Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA: Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 1993;361 (6412):539-541.
31. Ridge JP, di Rosa F, Matzinger P: A conditioned dendritic cell can be a temporal bridge between a CD4+ T- helper and a T-killer cell. Nature 1998;393(6684):474-478.
32. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ: T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998;393(6684):480-483.
33. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR: Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998;393(6684):478-80.
34. Fischbein MP, Ardehali A, Yun J, Schoenberger S, Laks H, Irie Y, Dempsey P, Cheng G, Fishbein MC, Bonavida B: CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants. J Immunol 2000;165(12):7316-7322.
35. Silverstein AM: The history of immunology: in Paul WE (ed): Fundamental Immunology. Philadelphia, Lippincott-Raven, 1999, pp 19-35.
36. Perillo N, Pace K, Seilhamer J, Baum L: Apoptosis of T cells mediated by galectin-1. Nature 1995;378:736-739.
37. Anderson M, Venanzi E, Chen Z, Berzins S, Benoist C, Mathis D: The cellular mechanism of Aire control of T cell tolerance. Immunity 2005;23(2):227-239.
38. Strand, S, Hofmann, WJ, Hug, H, Muller, M, Otto, G, Strand, D, Mariani, SM, Stremmel, W, Krammer, PH, Galle, PR, Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? [see comments]. Nat Med 1996;2(12):1361-1366.
39. Chambers C, Sullivan T, Allison J: Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. Immunity 1997;7(6):885-895.
40. Chen W, Jin W, Wahl S: Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells. J Exp Med 1998;188(10):1849-1857.
41. Chatenoud L, Salomon B, Bluestone J: Suppressor T cells - they're back and critical for regulation of autoimmunity! Immunol Rev 2001;182:149-163.
42. Sakaguchi S: Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000;101(5):455-458.
43. Khattri R, Cox T, Yasayko S, Ramsdell F: An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003;4(4):337-342.
44. Pober JS, Cotran RS: The role of endothelial cells in inflammation. Transplantation 1990;50(4):537-544.
45. Austrup F, Vestweber D, Borges E, Löhning M, Bräuer R, Herz U, Renz H, Hallmann R, Scheffold A, Radbruch A, Hamann A: P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 1997;385:81-83.
46. Fink PJ, McMahan CJ: Lymphocytes rearrange, edit and revise their antigen receptors to be useful yet safe. Immunol Today 2000;21(11):561-566.
47. Mackay CR, Marston WL, Dudler L: Naive and memory T cells show distinct pathways of lymphocyte recirculation. J Exp Med 1990;171(3):801-817.
48. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401(6754):708-712.
49. Lichtman AH, Ding H, Henault L, Vachino G, Camphausen R, Cumming D, Luscinskas FW: CD45RA-RO+ (memory) but not CD45RA+RO-(naive) T cells roll efficiently on E- and P-selectin and vascular cell adhesion molecule-1 under flow. J Immunol 1997;158(8):3640-3650.
50. Campbell JJ, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P, Andrew DP, Warnke R, Ruffing N, Kassam N, Wu L, Butcher EC: The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999;400(6746):776-780.
51. Hauser I, Johnson D, Madri J: Differential induction of VCAM-1 on human iliac venous and arterial endothelial cells and its role in adhesion. J Immunol 1993;151:5172-5185.
52. Johnson D, Hauser I, Voll R, Emmrich F: Arterial and venular endothelial cell costimulation of cytokine secretion by human T cell clones. J Leuk Biol 1998;63:612-619.
53. Corr M, Slanetz A, Boyd L, Jelonek M, Khilko S, Al-Ramadi B, Kim Y, Maher S, Bothwell A, Margulies D: T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science 1994;265:946-949.
54. Valitutti S, Muller S, Cella M, Padovan E, Lanzavecchia A: Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995;375:148-151.
55. Viola A, Lanzavecchia A: T cell activation determined by T cell receptor number and tunable thresholds. Science 1996;273(5271):104-106.
56. Hauzenberger D, Klominek J, Bergstrom SE, Sundqvist KG: T lymphocyte migration: The influence of interactions via adhesion molecules, the T cell receptor, and cytokines. Crit Rev Immunol 1995;15:285-316.
57. Dustin M, Springer T: T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 1989;341:619-624.
58. Shimizu Y, van Seventer G, Horgan K, Shaw S: Regulated expression and binding of three VLA (β1) integrin receptors on T cells. Nature 1990;345:250-253.
59. Camp R, Scheynius A, Johansson C, Puré E: CD44 is necessary for optimal contact allergic response but is not required for normal leukocyte extravasation. J Exp Med 1993;178:497-507.
60. Ebnet K, Kaldjian E, Anderson A, Shaw S: Orchestrated information transfer underlying leukocyte endothelial interactions. Ann Rev Immunol 1996;14:155-177.
61. Issekutz T, Webster D, Stoltz J: Lymphocyte recruitment in vaccinia virus-induced cutaneous delayed-type hypersensitivity. Immunology 1986;58:87-94.
62. Marelli-Berg FM, Scott D, Bartok I, Peek E, Dyson J, Lechler RI: Activated murine endothelial cells have reduced immunogenicity for CD8+ T cells: a mechanism of immunoregulation? J Immunol 2000;165(8):4182-4189.
63. Sullivan GW, Sarembock IJ, Linden J: The role of inflammation in vascular diseases. J Leukoc Biol 2000;67(5):591-602.
64. Albelda S, Smith C, Ward P: Adhesion molecules and inflammatory injury. FASEB J 1994;8:504-512.
65. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340(2):115-126.
66. Springer T: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-304.
67. Koga S, Novick AC, Toma H, Fairchild RL: CD8+ T cells produce RANTES during acute rejection of murine allogeneic skin grafts. Transplantation 1999;67(6):854-864.
68. Hynes R: Integrins: versatility, modulation, and signalling in cell adhesion. Cell 1992;69:11-25.
69. Campbell J, Hedrick J, Zlotnik A, Siani M, Thompson D, Butcher E: Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 1998;279:381-384.
70. Issekutz TB, Stoltz JM, van der Meide P: Lymphocyte recruitment in delayed type hypersensitivity, the role of IFN-gamma. J Immunol 1988;140(2928):2928-2993.
71. Kündig T, Althage A, Hengartner H, Zinkernagel R: Skin test to assess virus-specific cytotoxic T-cell activity. Proc Natl Acad Sci U S A 1992;89:7757-7761.
72. Müller U, Steinhoff U, Reis L, Hemmi S, Pavlovic J, Zinkernagel R, Aguet M: Functional role of type I and type II interferons in antiviral defense. Science 1994;264:1928-1921.
73. de Boer OJ, van der Wal AC, Becker AE: Atherosclerosis, inflammation, and infection. J Pathol 2000;190(3):237-243.
74. Burnett MS, Gaydos CA, Madico GE, Glad SM, Paigen B, Quinn TC, Epstein SE: Atherosclerosis in apoE knockout mice infected with multiple pathogens. J Infect Dis 2001;183(2):226-231.
75. Ouchi K, Fujii B, Kudo S, Shirai M, Yamashita K, Gondo T, Ishihara T, Ito H, Nakazawa T: Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic tissue. J Infect Dis 2000;181:8441-443.
76. Schoen F: Blood vessels; in Cotran R, Kumar V, Robbins S (eds): Pathologic Basis of Disease, 5th ed. Philadelphia, WB Saunders, 1994, pp 467-516.
77. Salomon RN, Hughes CC, Schoen FJ, Payne DD, Pober JS, Libby P: Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol 1991;138(4):791-798.
78. Hansson G: Immune responses in atherosclerosis; in Hansson G, Libby P (eds): Immune Functions of the Vessel Wall. Amsterdam, Harwood Acadademic Press, 1996, pp 143-158.
79. Ludewig B, Freigang S, Jaggi M, Kurrer MO, Pei YC, Vlk L, Odermatt B, Zinkernagel RM, Hengartner H: Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model. Proc Natl Acad Sci U S A 2000;97(23):12752-12757.
80. Fong I: Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis. J Infect Dis 2000;181(3):S514-18.
81. Handin R: Disorders of coagulation and thrombosis (chapter 118); in Fauci A, et al (eds): Principles of Internal Medicine. New York, McGraw-Hill, 1998, pp 736-743.
82. Cosgriff TM: Mechanisms of disease in Hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev Infect Dis 1991;13(1):97-107.
83. Petkova SB, Huang H, Factor SM, Pestell RG, Bouzahzah B, Jelicks LA, Weiss LM, Douglas SA, Wittner M, Tanowitz HB: The role of endothelin in the pathogenesis of Chagas' disease. Int J Parasitol 2001;31(5-6):498-510.
84. NIH-NHLBI: www.nhlbi.nih.gov/health/pubhc/heart/other/hrt_lung.htm.
85. NIH-NHLBI: www.nhlbi.nih.gov/health/public/heart/other/chdfacts.htm.
86. Sykes M: Immunobiology of transplantation. Faseb J 1996;10(7):721-730.
87. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y, et al: The Banff 97 working classification of renal allograft pathology. Kidney Int 1999;55(2):713-723.
88. Ross R: Atherosclerosis: a question of endothelial integrity and growth control of smooth muscle. Harvey Lectures 1982;77:161-182.
89. Hruban R, Beschorner W, Baumgartner W, Augustine S, Ren H, Reitz B, Hutchins G: Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis. Am J Pathol 1990;137:871-882.
90. De Waal RM, Bogman MJ, Maass CN, Cornelissen LM, Tax WJ, Koene RA: Variable expression of Ia antigens on the vascular endothelium of mouse skin allografts. Nature 1983;303(5916):426-429.
91. Shi C, Lee WS, He Q, Zhang D, Fletcher D Jr, Newell J, Haber E: Immunologic basis of transplant-associated arteriosclerosis. Proc Natl Acad Sci U S A 1996;93:4051-4056.
92. Glas R, Franksson L, Öhlen C, Höglund P, Koller B, Ljunggren HG, Kärre K: Major histocompatibility complex I-specific and -restricted killing of β2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes. Proc Natl Acad Sci U S A 1992;89:11381-11385.
93. Zijlstra M, Auchincloss H Jr, Loring J, Chase C, Russell P, Jaenish R: Skin graft rejection by β2-microglobulin-deficient mice. J Exp Med 1992;175:885-893.
94. Quinn DG, Zajac AJ, Hioe CE, Frelinger JA: Virus-specific, CD8+ major histocompatibility complex class I- restricted cytotoxic T lymphocytes in lymphocytic choriomeningitis virus-infected beta2-microglobulin-deficient mice. J Virol 1997;71(11):8392-8396.
95. Shi C, Feinberg MW, Zhang D, Patel A, Sim CU, Dong ZM, Chapman SM, Gutierrez-Ramos JC, Wagner DD, Sibinga NE, Haber E: Donor MHC and adhesion molecules in transplant arteriosclerosis. J Clin Invest 1999;103(4):469-474.
96. Maier S, Tertilt C, Chambron N, Gerauer K, Huser N, Heidecke CD, Pfeffer K: Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice. Nat Med 2001;7(5):557-562.
97. Hughes CC, Pober JS: Costimulation of peripheral blood T cell activation by human endothehal cells. Enhanced IL-2 transcription correlates with increased c-fos synthesis and increased Fos content of AP-1. J Immunol 1993;150(8 Pt 1):3148-3160.
98. St. Louis J, Lederer J, Lichtman A: Costimulator deficient antigen presentation by an endothehal cell line induces a nonproliferative T cell activation response without anergy. J Exp Med 1993;178:1597-1605.
99. Kosaka H, Surh CD, Sprent J: Stimulation of mature unprimed CD8+ T cells by semiprofessional antigen- presenting cells in vivo. J Exp Med 1992;176(5):1291-1302.
100. Geppert T, Lipsky P: Antigen presentation by interferon-gamma-treated endothehal cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. J Immunol 1985;135:3750-3762.
101. Vora M, Yssel H, de Vries J, Karasek M: Antigen presentation by human dermal microvascular endothehal cells. Immunoregulatory effect of IFN-γ and IL-10. J. Immunol 1994;152:5734-5741.
102. Briscoe DM, Renault LE, Geehan C, Alexander SI, Lichtman AH: Human endothelial cell costimulation of T cell IFN-gamma production. J Immunol 1997;159(7):3247-3256.
103. Hughes C, Savage C, Pober JS: Endothehal cells augment T cell interleukin 2 production by a contact-dependent mechanism involving CD2/LFA-3 interaction. J Exp Med 1990;171(1453):1453-1467.
104. Savage C, Hughes C, Pepinsky R, Wallner B, Freedman A, Pober J: Endothehal cell Lymphocyte Function-associated Antigen-3 and an unidentified ligand act in concert to provide co-stimulation to human peripheral blood CD4+ T cells. Cell Immunol 1991;137:150-163.
105. Perez VL, Henault L, Lichtman AH: Endothelial antigen presentation: stimulation of previously activated but not naive TCR-transgenic mouse T cells. Cell Immunol 1998;189(1):31-40.
106. Ma W, Pober JS: Human endothelial cells effectively costimulate cytokine production by, but not differentiation of, naive CD4+ T cells. J Immunol 1998;161(5):2158-2167.
107. Epperson D, Pober J: Antigen-presenting function of human endothehal cells. Direct activation of resting CD8 T cells. J Immunol 1994;153:5402-5412.
108. Dengler TJ, Johnson DR, Pober JS: human vascular endothelial cells stimulate a lower frequency of alloreactive CD8(+) Pre-CTL and induce less clonal expansion than matching B lymphoblastoid cells: development of a novel limiting dilution analysis method based on CFSE labeling of lymphocytes. J Immunol 2001;166(6):3846-3854.
109. Biedermann BC, Pober JS: Human vascular endothelial cells favor clonal expansion of unusual alloreactive CTL. J Immunol 1999;162(12):7022-7030.
110. Hancock WW, Sayegh MH, Zheng XG, Peach R, Linsley PS, Turka LA: Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA 1996;93(24):13967-13972.
111. Ehrlich H: Culture of Aorta; in Harris C, Trump B, Stoner G (eds): Methods in Cell Biology, Normal Human Tissue and Cell Culture A (Respiratory, Cardiovascular, and Integumentary Systems). New York, Academic Press, 1980, pp 117-134.
112. Striker G, Harlan J, Schwartz S: Human endothelial cells in vitro; in Harris C, Trump B, Stoner G (eds): Methods in Cell Biology, Normal Human Tissue and Cell Culture A (Respiratory, Cardiovascular, and Integumentary Systems). New York, Academic Press, 1980, pp 136-150.
113. Roskelley CD, Desprez PY, Bissell MJ: Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc Natl Acad Sci U S A 1994;91(26):12378-12382.
114. Theopold U, Kohler G: Partial tolerance in beta-galactosidase-transgenic mice. Eur J Immunol 1990;20(6):1311-1316.
115. Borrow P, Cornell JL, Ruppe MD, Mucke L: Immunization-induced inflammatory infiltration of the central nervous system in transgenic mice expressing a microbial antigen in astrocytes. J Neuroimmunol 1995;61(2):133-149.
116. Aird W, Edelberg J, Weiler-Guettler H, Simmons W, Smith T, Rosenberg R:Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. J Cell Biol 1997;138:1117-1124.
117. Schlaeger TM, Bartunkova S, Lawitts JA, Teichmann G, Risau W, Deutsch U, Sato TN: Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc Natl Acad Sci U S A 1997;94(7):3058-3063.
118. Jax: jaxmice.jax.org/library/notes/447c.html.
119. Price J, Turner D, Cepko C: Lineage analysis in the vertebrate nervous system by retrovirus- mediated gene transfer. Proc Natl Acad Sci U S A 1987;84(1):156-160.
120. Williams RS, Johnston SA, Riedy M, DeVit MJ, McElligott SG, Sanford JC: Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc Natl Acad Sci U S A 1991;88(7):2726-2730.
121. Tang DC, DeVit M, Johnston SA: Genetic immunization is a simple method for eliciting an immune response. Nature 1992;356(6365):152-154.
122. Corr M, Lee DJ, Carson DA, Tighe H: Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med 1996;184(4):1555-1560.
123. Leclerc C, Deriaud E, Rojas M, Whalen R: The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA. Cell Immunol 1997;179:97-106.
124. Pfeifer JD, Wick MJ, Roberts RL, Findlay K, Normark SJ, Harding CV: Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 1993;361(6410):359-362.
125. Fenton RG, Keller CJ, Hanna N, Taub DD: Induction of T-cell immunity against Ras oncoproteins by soluble protein or Ras-expressing Escherichia coli. J Natl Cancer Inst 1995;87(24):1853-1861.
126. Speidel K, Osen W, Faath S, Hilgert I, Obst R, Braspenning J, Momburg F, Hammerling G, Rammensee H: Priming of cytotoxic T lymphocytes by five heat-aggregated antigens in vivo: conditions, efficiency, and relation to antibody responses. Eur J Immunol 1997;27:2391-2399.
127. Johnson D, Faherty D, Zauderer M: TTGG-A - L-specific memory B cells induced in low responder strains. J Immunol 1984;137:2791-2795.
128. Brubaker JO, Thompson CM, Morrison LA, Knipe DM, Siber GR, Finberg RW: Th1-associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus. J Immunol 1996;157(4):1598-604.
129. Kyburz D, Aichele P, Speiser DE, Hengartner H, Zinkernagel RM, Pircher H: T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur J Immunol 1993;23(8):1956-1962.
130. Newman K, Dunn P, Owens J, Schulick A, Virmani R, Sukhova G, Libby P, Dichek D: Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest 1995;96:2955-2965.